11![Assessment Run H7HER-2 ISH (BRISH or FISH) Material Table 1. Content of the multi-block used for the NordiQC HER-2 ISH assessment, run H7 HER-2 IHC* Assessment Run H7HER-2 ISH (BRISH or FISH) Material Table 1. Content of the multi-block used for the NordiQC HER-2 ISH assessment, run H7 HER-2 IHC*](https://www.pdfsearch.io/img/a706767d8db8cb68081d92cfc7660409.jpg) | Add to Reading ListSource URL: www.nordiqc.orgLanguage: English |
---|
12![Trastuzumab sc (bröstca) Trastuzumab (Herceptin) 600 mg/ 5 ml (standarddos) sc.inj. Trastuzumab sc (bröstca) Trastuzumab (Herceptin) 600 mg/ 5 ml (standarddos) sc.inj.](https://www.pdfsearch.io/img/f35a63a236cf79549f03fc6e66592574.jpg) | Add to Reading ListSource URL: www.cancercentrum.se- Date: 2015-02-13 07:22:40
|
---|
13![Pertuzumab/Trastuzumab sc Pertuzumab (Perjeta) Trastuzumab (Herceptin) standarddos laddningsdos (bröstca) 840 mg Pertuzumab/Trastuzumab sc Pertuzumab (Perjeta) Trastuzumab (Herceptin) standarddos laddningsdos (bröstca) 840 mg](https://www.pdfsearch.io/img/3e0937ae31786d2c7a5066cbb6d652e7.jpg) | Add to Reading ListSource URL: www.cancercentrum.se- Date: 2015-02-13 07:14:58
|
---|
14![landmarks Breast cancer PROLONGING AND CURTAILING ADJUVANT TRASTUZUMAB IN HER2+ EARLY BREAST CANCER Caroline Lohrisch, MD, FRCPC, Medical Oncologist, Vancouver Cancer Centre; Chair, Breast Cancer Systemic Therapy Committ landmarks Breast cancer PROLONGING AND CURTAILING ADJUVANT TRASTUZUMAB IN HER2+ EARLY BREAST CANCER Caroline Lohrisch, MD, FRCPC, Medical Oncologist, Vancouver Cancer Centre; Chair, Breast Cancer Systemic Therapy Committ](https://www.pdfsearch.io/img/573f516677de8128d4bd2fa5197956b9.jpg) | Add to Reading ListSource URL: www.oncologyex.comLanguage: English - Date: 2013-02-19 15:43:44
|
---|
15![Trastuzumab iv/Docetaxel Trastuzumab (Herceptin) laddningsdos Trastuzumab (Herceptin) underhållsdos Trastuzumab iv/Docetaxel Trastuzumab (Herceptin) laddningsdos Trastuzumab (Herceptin) underhållsdos](https://www.pdfsearch.io/img/a7edc4a95485ba05ab3f05bf1d9a1ff6.jpg) | Add to Reading ListSource URL: www.cancercentrum.seLanguage: Swedish - Date: 2015-02-13 07:40:13
|
---|
16![Pertuzumab/Trastuzumab sc Pertuzumab (Perjeta) Trastuzumab (Herceptin) standarddos underhållsdos (bröstca) 420 mg Pertuzumab/Trastuzumab sc Pertuzumab (Perjeta) Trastuzumab (Herceptin) standarddos underhållsdos (bröstca) 420 mg](https://www.pdfsearch.io/img/f151644a766048930a73683fee0d8a59.jpg) | Add to Reading ListSource URL: www.cancercentrum.se- Date: 2015-02-13 07:18:57
|
---|
17![Trastuzumab sc/Docetaxel(Bröstca) Trastuzumab (Herceptin) 600 mg/ 5 ml sc inj 2-5 min Dag 1 2 Trastuzumab sc/Docetaxel(Bröstca) Trastuzumab (Herceptin) 600 mg/ 5 ml sc inj 2-5 min Dag 1 2](https://www.pdfsearch.io/img/521f4c3832ab781a0dbc533e857fcc2a.jpg) | Add to Reading ListSource URL: www.cancercentrum.seLanguage: Swedish - Date: 2015-02-13 07:44:33
|
---|
18![Trastuzumab iv Trastuzumab (Herceptin) laddningsdos Trastuzumab (Herceptin) underhållsdos Trastuzumab iv Trastuzumab (Herceptin) laddningsdos Trastuzumab (Herceptin) underhållsdos](https://www.pdfsearch.io/img/7dc6ac25aee79113d05de4f419fa1a2f.jpg) | Add to Reading ListSource URL: www.cancercentrum.se- Date: 2015-02-13 07:27:26
|
---|
19![An Analytics Approach to Designing Clinical Trials for Cancer Dimitris Bertsimas Sloan School and Operations Research Center, Massachusetts Institute of Technology, Allison O’Hair, Stephen Relyea, and An Analytics Approach to Designing Clinical Trials for Cancer Dimitris Bertsimas Sloan School and Operations Research Center, Massachusetts Institute of Technology, Allison O’Hair, Stephen Relyea, and](https://www.pdfsearch.io/img/3513e8b37f311cdc5862d2a5355a86d0.jpg) | Add to Reading ListSource URL: web.mit.eduLanguage: English - Date: 2013-06-11 10:37:10
|
---|
20![Faculty & Friends no effect. The problem is not a lack of insulin, but a failure of its signal. PTP1B’s role in insulin signaling is normally to antagonize it, via dephosphorylation of the receptor. But, “if you can Faculty & Friends no effect. The problem is not a lack of insulin, but a failure of its signal. PTP1B’s role in insulin signaling is normally to antagonize it, via dephosphorylation of the receptor. But, “if you can](https://www.pdfsearch.io/img/ce2a15b46d85b4a40308ba0d30d6b5ff.jpg) | Add to Reading ListSource URL: www.cshl.eduLanguage: English - Date: 2012-05-15 16:38:26
|
---|